Ataxia Treatment Market: Introduction
Ataxia is a degenerative disease of the nervous system, which causes movement disorder. Patients of ataxia have issues while moving parts of body or the muscles in the arms and legs without coordination Symptoms of ataxia include lack of coordination, difficulty in walking, trouble while eating & swallowing, slurred speech, tremors, deterioration of fine motor skills, etc.
Read Report Overview - https://www.transparencymarketresearch.com/ataxia-treatment-market.html
Ataxia primarily occurs due to genetic factors, which are hereditary or familial, and acquired factors such as vitamin deficiencies, autoimmune conditions, some infections, exposure to toxic substances or drugs (especially alcohol), and various cancers There is no specific treatment for ataxia itself. If ataxia is a symptom of another disorder, the physician is likely to treat that disorder. Symptoms are generally treated by medications.
Key Drivers and Restraints of Global Ataxia Treatment Market
Rise in prevalence of ataxia with improving diagnosis rate and technological advancements in pharmacotherapy to treat symptoms of ataxia are key drivers fueling the ataxia treatment market For instance, as per data provided by National Organization for Rare Disorders (NORD), the prevalence of Friedreich’s Ataxia (FRDA) is around 1 in 40,000 people. FRDA is a highly common inherited ataxia in Europe, the Middle East, South Asia (Indian subcontinent), and North Africa Extensive research and development activities with pipeline drugs is also driving the global ataxia treatment market Government initiatives to increase awareness about ataxia and support provided by various organizations are also major factors boosting the ataxia treatment market However, no single product approved for treatment of ataxia is hampering the global ataxia treatment market Recent expiry of certain drugs that treat symptomatic ataxia is also restraining the ataxia treatment market
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php? flag=B&rep_id=79517 Pharmacotherapy Segment Dominated Global Ataxia Treatment Market
In terms of treatment type, the global ataxia treatment market can be segmented into pharmacotherapy, physical therapy, speech therapy, and others The pharmacotherapy segment accounted for a major share of the global market in 2019 due to better efficacy to treat symptoms, long-lasting effects, and pipeline products
Genetic Ataxia to Witness Significant Growth
In terms of disease type, the global ataxia treatment market can be divided into genetic ataxia, acquired ataxia, and idiopathic